Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis

Van der Heijde, D, Landewé, RB, Mease, PJ et al. (6 more authors) (2016) Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis. Arthritis & Rheumatology, 68 (8). pp. 1914-1921. ISSN 2326-5191

Abstract

Metadata

Authors/Creators:
  • Van der Heijde, D
  • Landewé, RB
  • Mease, PJ
  • McInnes, IB
  • Conaghan, PG
  • Pricop, L
  • Ligozio, G
  • Richards, HB
  • Mpofu, S
Copyright, Publisher and Additional Information: © 2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Keywords: Autoinflammatory diseases; biologicals; inflammation; interleukins
Dates:
  • Accepted: 15 March 2016
  • Published (online): 27 July 2016
  • Published: August 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 17 May 2016 09:48
Last Modified: 19 Apr 2017 10:34
Published Version: http://dx.doi.org/10.1002/art.39685
Status: Published
Publisher: Wiley
Identification Number: https://doi.org/10.1002/art.39685
Related URLs:

Export

Statistics